Page last updated: 2024-10-27

fenofibrate and Asthma

fenofibrate has been researched along with Asthma in 4 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research Excerpts

ExcerptRelevanceReference
"In this study, we showed that administration of 10 and 30 mg/kg fenofibrate effectively attenuated airway hyperresponsiveness and inflammation in a mouse model of allergic asthma, possibly through inhibition of NF-κB binding activity."8.31Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity. ( Alhirmizi, IAO; Arslan, SO; Bayram, KK; Koç, A; Özünlü, SAÇ; Parlar, A; Uysal, F, 2023)
"In this study, we showed that administration of 10 and 30 mg/kg fenofibrate effectively attenuated airway hyperresponsiveness and inflammation in a mouse model of allergic asthma, possibly through inhibition of NF-κB binding activity."4.31Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity. ( Alhirmizi, IAO; Arslan, SO; Bayram, KK; Koç, A; Özünlü, SAÇ; Parlar, A; Uysal, F, 2023)
"Treatment with fenofibrate (0."1.35Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate. ( Auwerx, J; Becker, J; Delayre-Orthez, C; Frossard, N; Pons, F, 2008)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Alhirmizi, IAO1
Uysal, F1
Arslan, SO1
Özünlü, SAÇ1
Koç, A1
Parlar, A1
Bayram, KK1
Elaidy, SM1
Essawy, SS1
Hussain, MA1
El-Kherbetawy, MK1
Hamed, ER1
Paw, M1
Wnuk, D1
Kądziołka, D1
Sęk, A1
Lasota, S1
Czyż, J1
Madeja, Z1
Michalik, M1
Delayre-Orthez, C1
Becker, J1
Auwerx, J1
Frossard, N1
Pons, F1

Other Studies

4 other studies available for fenofibrate and Asthma

ArticleYear
Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity.
    Respiratory physiology & neurobiology, 2023, Volume: 314

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models,

2023
Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cytokines; Fenofib

2018
Fenofibrate Reduces the Asthma-Related Fibroblast-To-Myofibroblast Transition by TGF-Β/Smad2/3 Signaling Attenuation and Connexin 43-Dependent Phenotype Destabilization.
    International journal of molecular sciences, 2018, Aug-29, Volume: 19, Issue:9

    Topics: Asthma; Cell Proliferation; Cell Survival; Cells, Cultured; Connexin 43; Fenofibrate; Fibroblasts; H

2018
Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
    European journal of pharmacology, 2008, Feb-26, Volume: 581, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Cytokines; Fenofibrate; Immunoglobulin E; Lipopolysacchar

2008